search
for
 About Bioline  All Journals  Testimonials  Membership  News


Memórias do Instituto Oswaldo Cruz
Fundação Oswaldo Cruz, Fiocruz
ISSN: 1678-8060 EISSN: 1678-8060
Vol. 90, Num. 4, 1995, pp. 513
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 90(4): 513 Jul/Aug. 1995

Detection of Anti-Schistosoma Antibodies in Oral Fluids

Maria Monica de Aguiar Garcia+, Marcia Nogueira Amorim, Luciana de GouvEa Viana, Teresa Cristina de Melo Garcia, Naftale Katz, Ana Lucia Teles Rabello

Laboratorio de Esquistossomose, Centro de Pesquisas Rene Rachou-FIOCRUZ, Av. Augusto de Lima 1715, 30190-002 Belo Horizonte, MG, Brasil

Code Number: OC95101
Size of Files:
    Text: 4K
    No associated graphics

Key words: Schistosoma mansoni - oral fluids - antibodies

The use of saliva and oral transudate samples has been suggested as a non-invasive alternative for detection of antibodies to a variety of viral agents including hepatitis A, B and C virus, rubella virus, HIV antigens (JV Parry et al. 1987 Lancet 2: 72-75, T Thieme et al. 1992 J Clin Microbiol 30: 1076-1079, H Tamashiro, NT Constantine 1994 Bull WHO 72: 135-143).

In this preliminary study, saliva and oral transudate from 14 patients with chronic schistosomiasis and 6 negative individuals were simultaneously tested for the presence of IgG and IgA antibodies against soluble S. mansoni egg antigen (SEA) by ELISA (MN Lunde et al. 1979 Am J Trop Med Hyg 28: 87-91). Serum from these groups was tested for the presence of IgG antibodies against SEA by ELISA.

Eggs of S. mansoni in feces were detected by Kato/Katz method with one stool examination (N Katz et al. 1972 Rev Inst Med Trop S Paulo 14: 297-340). Fourteen patients (age range 13-19 years, geometric mean number of S. mansoni eggs = 488.14, range 12-2232) were studied. Six individuals (age range 27-62 years) who have never lived in an endemic area and who had had three negative stool examination, formed the control group.

Saliva from both groups was obtained with SDS Omni-Sal, Saliva Diagnostics Systems, Vancouver, WA, USA. The fluid content of the pad is expelled by using a separator. The supernatant, which represents a 1:2 dilution, is then used directly for testing.

For the collection of the oral transudate from both groups, the collect device Ora Sure®, Epitope Inc., Beaverton, OR, USA was used. The fluid content of the pad is expelled by refrigerated centrifugation and tested without further dilution.

Blood samples were taken by venopuncture. The serum, saliva and oral transudate obtained were stored at -20 C until use.

ELISA - Polystyrene plates (Nunc Immunoplate Maxshorp® - Nunc Denmark) were coated with SEA and blocked according to ALT Rabello et al. (1992 Mem Inst Oswaldo Cruz 87: 187-190). Sera were tested at 1:100 dilution and reaction was considered positive when the optical density was higher than the mean plus two standard deviations of six negative control sera.

Presence of IgG and IgA antibodies to SEA in saliva and oral transudate were tested. Reaction was considered positive when the optical density was higher than the mean plus two standard deviations of six negative control saliva or oral transudate.

For statistic analysis the SAS software and guides (SAS version 6, SAS Institute Inc., North Caroline, USA) were used. All variables were individually tested by the W test of normality (SS Shapiro, MB Wilk 1965 Biometrika 52: 591-611). The coefficient of correlation of Pearson was used.

Sensitivity obtained for IgG detection using saliva, oral transudate and serum was 100%. For IgA detection, sensitivity was 28.6 and 42.0%, in saliva and oral transudate, respectively. Specificity was 100% for IgG and IgA detection using all specimens.

The coefficient of correlation of Pearson of specific anti-S. mansoni antibodies IgG between serum and oral transudate was r = 0.73 (p = 0.0002) and between serum and saliva was r = 0.44 (p = 0.05).

Demonstration of anti-S. mansoni antibodies in saliva and oral transudate seems to be a promising test for diagnosis of S. mansoni infection. A comprehensive investigation of a larger number of positive and negative endidual patients is in progress.

Acknowledgements: to SDS Omni-Sal, Saliva Diagnostics Systems, Ora Sure, Epitope for the collection devices and Dr Andrew Simpson for critical review of the manuscript.

Copyright 1995 Fundacao Oswaldo Cruz

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil